Glioblastoma is a dangerous brain malignancy click here known for its rapid growth and insensitivity to typical treatments. Investigations are constantly underway to identify new management strategies, and recently, a new biomarker named LCA168 has emerged as a potential target for glioblastoma treatment. LCA168 is a protein that is abundantly pro